Lopez-Casasnovas

Source Lopez-Casasnovas, G., V. Ortun and C. Murillo (1999), El sistema sanitario espanol informe de una decada, Bilbao Fundacion BBV. 

Source Own data, from J. Puig-Junoy8 and G. Lopez-Casasnovas and J. Puig-Jimoy.6... 

Lopez-Casasnovas, G. (1999), Health care and cost containment in Spain , in E. Mossialos, J. Le Grand (eds), Health Care and Cost Containment in the European Union, London Ashgate, pp. 401—42. 

Lobo, F. (1997), La creation de un mercado de medicamentos genericos en Espana , in G. Lopez-Casasnovas and D. Rodriguez (eds), La regulation de los servicios sanitarios en Espana, Madrid Civitas, pp. 393 436. 

Puig-Junoy, J. and G. Lopez-Casasnovas (1999), La aplicacion de precios de referencia a los medicamentos , Cuademos de Informacion Econdmica, 143, 77-84. 

Antonanzas, F., J. Rovira and C. Juarez (1999), La demanda de medicamentos un metodo para calcular las repercusiones presupuestarias , in G. Lopez-Casasnovas and J. Callau (eds), Libro de Ponencias de las XIX Jornadas de Economla de la Salud, June 2-4 [abstract only], Zaragoza, Huesca Asociacion de Economia de la Salud, pp. 407-408. 

G. Lopez-Casasnovas Research Centre for Economics and Health (CRES) university professor, Department of Economics and Business, Pompeu Fabra University, Barcelona... 

Remarkably, however, economists can be found who reject the idea of reference pricing on two grounds (see, e.g., Danzon 2000 and 2001, and the series of essays in Lopez-Casasnovas and Jbnsson 2001). That opposition comes even from economists who favor the idea of defined contributions for health insurance (see, e.g., Danzon, coauthor in Pauly et al. 1991). 

Danzon, Patricia M. 2001. Reference Pricing Theory and Evidence, in Reference Pricing and Pharmaceutical Policy, ed. by G. Lopez-Casasnova and B. Jonsson, 86-126. 

Lopez-Casasnovas, G. and J. Puig-Junoy. 2000. Review of the Literature on Reference Pricing. Health Policy 54 87-123. 

---